![Menghisteab Bairu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Menghisteab Bairu
Director/Board Member at
BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 18 000 $ as of 2026-05-30
Profile
Menghisteab Bairu is the founder of Proxenia Venture Partners LLC, founded in 2016, serving as Chairman and CEO.
Dr. Bairu is the founder of Bio Usawa, Inc., founded in 2023, serving as President and Chief Executive Officer.
Dr. Bairu is the founder of Serenus Biotherapeutics, Inc., founded in 2013, serving as Chairman-Emeritus.
Dr. Bairu is the founder of Bairex Health, founded in 2019, served as Chairman and Chief Executive Officer.
Current jobs include Independent Director at Brainstorm Cell Therapeutics, Inc. since 2021 and Board Member at Himalayan Cataract Project since 2021.
Former jobs include President and Chief Executive Officer at Speranza Therapeutics, Inc., Executive Chairman at Treos Bio Ltd. from 2016 to 2019, Director at Alzheon, Inc., Director at A-CUBE, Inc., Medical Director at Fremont Health Corp., Chief Medical Officer and Head-Development at Elan Corp.
Plc from 2013 to 2014, Board Member at NewBridge Pharmaceuticals FZ LLC from 2013 to 2014, and Executive Vice President at Prothena Therapeutics Ltd. from 2011 to 2013.
Education includes a doctorate from the University of Milan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-25 | 24,000 ( 0.22% ) | 18 000 $ | 2026-05-30 |
Menghisteab Bairu active positions
| Companies | Position | Start |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Director/Board Member | 2021-10-27 |
Serenus Biotherapeutics, Inc.
 Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Distributes and manufactures pharmaceutical drug products | Founder | 2012-12-31 |
Proxenia Venture Partners LLC
 Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Chief Executive Officer | 2016-11-30 |
Himalayan Cataract Project
 Himalayan Cataract Project Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that helps people to retain sight | Director/Board Member | 2021-08-31 |
Former positions of Menghisteab Bairu
| Companies | Position | End |
|---|---|---|
Treos Bio Ltd.
 Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and manufactures immunotherapy medicines | Chairman | 2018-12-31 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Chief Tech/Sci/R&D Officer | 2014-04-23 |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, therapeutics, and medical devices | Director/Board Member | 2013-12-31 |
Prothena Therapeutics Ltd.
 Prothena Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business services | Private Equity Investor | 2012-12-31 |
Speranza Therapeutics, Inc.
 Speranza Therapeutics, Inc. Information Technology ServicesTechnology Services Operates as a medical technology company | Chief Executive Officer | - |
Training of Menghisteab Bairu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
65
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops drugs for neurodegenerative disorders | Health Technology |
University of Milan
 University of Milan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NewBridge Pharmaceuticals FZ LLC
NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, therapeutics, and medical devices | Health Technology |
A-CUBE, Inc.
 A-CUBE, Inc. BiotechnologyHealth Technology Develops novel antibodies | Health Technology |
Fremont Health Corp.
 Fremont Health Corp. Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Himalayan Cataract Project
Himalayan Cataract Project Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that helps people to retain sight | Commercial Services |
Prothena Therapeutics Ltd.
Prothena Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides business services | Commercial Services |
Serenus Biotherapeutics, Inc.
Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Distributes and manufactures pharmaceutical drug products | Distribution Services |
Treos Bio Ltd.
Treos Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and manufactures immunotherapy medicines | Commercial Services |
Proxenia Venture Partners LLC
Proxenia Venture Partners LLC Investment ManagersFinance Proxenia Venture Partners invests in companies located across the global. The firm targets companies operating in the fields of healthcare, energy, water, agriculture, and sustainability. It provides financing for seed and early stage capital requirements with an investment size of USD 50 - 25 Million. | Finance |
Speranza Therapeutics, Inc.
Speranza Therapeutics, Inc. Information Technology ServicesTechnology Services Operates as a medical technology company | Technology Services |
Bairex
 Bairex Internet Software/ServicesTechnology Services Specializes in hands-on educational activities for physicians, clinical trialists, nurses, regulators and pharmacovigilance officers | Technology Services |
- Stock Market
- Insiders
- Menghisteab Bairu
